AGENCIES,NOVEMBER 17 2021: Drugmaker Pfizer Inc. para deal kurishe U.N.-backed group logote etu bi dusra manufacturers khan ke experimental COVID-19 pill kuribole niemte ekta move ase etu para etu elach toh thakibole niemte duniya te population te adha te thakibo.
Statement toh Tuesday te diya toh Pfizer para koikena janaishe etu para license dibo antiviral pi ll nimete Geneva-based Medicines Patent Pool, etu para generic drug companies para etu pill chulabole 95 desh te etu para 53 percent world population ase.
Etu deal te kunba dangor desh khan nai kuntu para coronavirus outbreak khan dukh paishe.example te etu te ekta Brazilian drug company toh license thakishe etu pill bonabole niemte export niemte dusra nimete etu medicine toh generically brazil te bonabole niemte.
Etia tak health officials khan koikena janaishe etu fact toh etu deal toh kurishe etu Pfizer pil toh authorize nakura akhe te etu para modot dibo pandemic toh joldi khotom kuribole nimete.
Etu agreement laga terms bithor te Pfizer toh royalties khan pabo sales khan te low income desh te aro etu para royalties kahn sales sob desh te uthabo etu agreement te cover kura toh aro covid19 toh ekta public health emergency hoishe.
Etu moina akhe te Pfizer toh etu laga pill hatadishe etu hospitalization laga risk aro death toh komti hoilebi 90 percent manu te mild para moderate coronavirus infection taka toh.independent experts para company study toh rkahishe promising result s dikena.
